RxDoctor Payments Data

Linda Neff, APRN

Family · Irvington, KYNPI 1336282375

Payments from drug & device makers

$824in general payments, 2019–2025

Across 48 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$165
  • Pfizer$161
  • Novo Nordisk$73
  • AbbVie$62
  • Lilly USA, LLC$56
  • Amgen$51
  • plus $255 from 11 others

What the payments were for

  • Food & beverage$824100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$824 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$63,790
Medicare patients
220
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$58,969
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$36,370
EliquisApixaban32$17,649
Repatha SureclickEvolocumab27$15,526
JanuviaSitagliptin Phosphate22$14,418
XareltoRivaroxaban23$12,478
FarxigaDapagliflozin Propanediol13$8,434
InvokanaCanagliflozin11$6,469
Ondansetron Hcl23$2,209
Arnuity ElliptaFluticasone Furoate11$2,159
Ventolin HfaAlbuterol Sulfate36$1,985
Albuterol Sulfate HfaAlbuterol Sulfate82$1,957
SynthroidLevothyroxine Sodium36$1,805
Celecoxib21$1,564
Varenicline Tartrate14$1,470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$58,96961 claims
GSKTrelegy Ellipta, Arnuity Ellipta$14$38,52956 claims
PfizerEliquis$161$17,64932 claims
MerckJanuvia$30$14,41822 claims
AstraZenecaFarxiga$42$8,43413 claims
AbbVieSynthroid$62$1,80536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.

Other family in Irvington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →